Rv3112 Molybdenum cofactor biosynthesis protein MoaD

Summary

Symbol Product Feature Type Start End Strand Length AA Length is TF
Rv3112 moaD1 Molybdenum cofactor biosynthesis protein MoaD CDS 3479700 3479951 + 252 83 FALSE

Rv3112 (Molybdenum cofactor biosynthesis protein MoaD) is predicted to be co-regulated in modules bicluster_0535 with residual 0.57 and bicluster_0587 with residual 0.58.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 11.00 and 3,000.00 for bicluster_0535 and 0.00 and 0.32 for bicluster_0587 respectively.

These modules are enriched for following go terms: .

This gene is found to be for growth on cholesterol.

Mutant available?:

Product (LegacyBRC) Product (RefSeq)
PROBABLE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN D MOAD1 [MOLYBDOPTERIN CONVERTING FACTOR SMALL SUBUNIT] [MOLYBDOPTERIN [MPT] CONVERTING FACTOR SUBUNIT 1] molybdenum cofactor biosynthesis protein D
Operon # Operon
2034 - -
PATRIC Locus Tag Enzyme Name PATRIC Pathways Transcriptomics

PATRIC

Not assigned Not assigned
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

Sulfur relay system

18
Total items in this category:  
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
57117058 YP_177928.1 Run
GO:0006790

sulfur compound metabolic process

sulfur compound metabolic process

Details: 
The chemical reactions and pathways involving the nonmetallic element sulfur or compounds that contain sulfur, such as the amino acids methionine and cysteine or the tripeptide glutathione.
GO Category: 
biological_process
3
Total items in this category:  
GO:0040007

growth

growth

Details: 
The increase in size or mass of an entire organism, a part of an organism or a cell.
GO Category: 
biological_process
621
Total items in this category:  
No TFOE experiment results were found

Quantitative Proteomics Data

t-test p-value Cholesterol/Glycerol Ratio
NA NA

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: